JPRN-UMIN000012903已完成2 期
Randomized phase II study of nab-Paclitaxel (nab-PTX) plus Carboplatin(CBDCA) followed by maintenance nab-PTX or TS-1 plus CBDCA followed by maintenance TS-1 as first-line treatment in patients with stage IIIB/IV squamous cell carcinoma of the lung. - Randomized phase II study of nab-PTX plus CBDCA followed by maintenance nab-PTX or TS-1 plus CBDCA followed by maintenance TS-1.
Internationanl University of Health and Welfare, Respiratory Disease center0 个研究点目标入组 58 人开始时间: 2014年2月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 58
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.History of hypersensitivity to drugs or albumin. 2.Severe infection 3.Significant comorbid disease (paresis of intestine, ileus, GI bleeding, uncontrolled angina pectoris, cardiac disease, etc) 4.Massive pleural and cardiac effusion and ascites required for tube drainage. 5.Cases of administration in the flucytosine. 6.Patients with superior vena cava syndrome. 7.Active synchronous malignant neoplasm. 8.Interstitial pneumonia or pulmonary fibrosis detectable on Chest X ray. 9.Brain metastases patients in need of treatment, such as an anti-seizure medication and steroids or have symptoms. 10.Cases of post-radiation to the primary tumor. 11.Cases of palliative bone or brain irradiation within two weeks of proposed entry to this study. 12.Uncontrolled psychiatric disease. 13.Pregnancy, breast feeding and suspected pregnancy. 14.Other conditions not suitable for this study.
研究者
相似试验
已完成
2 期
A phase 2 study of nab-Paclitaxel followed by FEC (Fluorouracil, Epirubicin, Cyclophosphamide) as primary therapy for operable breast cancerBreast CancerJPRN-UMIN000009733Hiroshima city hospital40
已完成
2 期
PhaseII study of Nab-paclitaxel followed by EC as neoadjuvant chemotherapy for the operable breast cancerBreast cancerJPRN-UMIN000022931Rakuwakai Otowa Hospital Breast oncology department24
已完成
2 期
Phase II pilot study of nab-paclitaxel in patients with metastatic or unresectable urothelial cancer previously treated with cisplatin-based chemotherapy.urothelial cancerJPRN-UMIN000015260Department of Urology, Saitama Medical Center, Saitama Medical University5
已完成
不适用
Phase II Study of nab-paclitaxel in Treated Patients with Advanced Non-Small Cell Lung CancerTreated patients with advanced non-small cell lung cancerJPRN-UMIN000015841Tohoku Medical and Pharmaceutical University30
招募中
2 期
Phase II study of nab-paclitaxel in combination with carboplatin in patients with refractory small-cell lung cancerRefractory small-cell lung cancerJPRN-UMIN000015565Dokkyo Medical University22